BioRestorative Therapies Total Current Liabilities

As of the most recent data (March 2026), BRTX shows a total current liabilities of $1.6M. That compares with $4.2M in the prior-year period — down 61.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BRTX's total current liabilities is now $1.6M (was $4.2M) — a 61.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether BioRestorative Therapies is outperforming or lagging.

Tracking BRTX's total current liabilities over time shows whether BioRestorative Therapies is scaling, shrinking, or reshaping that part of the business. The current reading is $1.6M That compares with $4.2M in the prior-year period — down 61.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has BioRestorative Therapies's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $1.6M) with ownership activity and broader fundamentals.

BioRestorative Therapies's total current liabilities is $1.6M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.